Hal Landy

1.2k total citations
25 papers, 384 citations indexed

About

Hal Landy is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Hal Landy has authored 25 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Hal Landy's work include Growth Hormone and Insulin-like Growth Factors (7 papers), Alkaline Phosphatase Research Studies (4 papers) and Glycogen Storage Diseases and Myoclonus (3 papers). Hal Landy is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (7 papers), Alkaline Phosphatase Research Studies (4 papers) and Glycogen Storage Diseases and Myoclonus (3 papers). Hal Landy collaborates with scholars based in United States, Canada and United Kingdom. Hal Landy's co-authors include N Stahnke, E Keller, W F Crowley, Aizeddin A. Mhanni, Michael P. Whyte, Edward Leung, Cheryl R. Greenberg, Martin H. Reed, A. Rees and Shereen Ezzat and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Clinical Chemistry and The Journal of Pediatrics.

In The Last Decade

Hal Landy

23 papers receiving 370 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hal Landy United States 10 205 102 87 82 58 25 384
Pilar Andaluz Spain 14 273 1.3× 266 2.6× 249 2.9× 61 0.7× 43 0.7× 20 539
Nicola Improda Italy 16 339 1.7× 152 1.5× 116 1.3× 32 0.4× 28 0.5× 36 527
Hatae Maesaka Japan 13 175 0.9× 179 1.8× 81 0.9× 27 0.3× 38 0.7× 29 438
S. C. Cwyfan Hughes United Kingdom 8 316 1.5× 102 1.0× 77 0.9× 15 0.2× 42 0.7× 8 364
J. Rodríguez‐Arnao United Kingdom 11 368 1.8× 76 0.7× 51 0.6× 16 0.2× 82 1.4× 13 479
Sezer Acar Türkiye 9 78 0.4× 94 0.9× 96 1.1× 19 0.2× 31 0.5× 48 366
Dan Nabriski Israel 10 167 0.8× 53 0.5× 30 0.3× 40 0.5× 23 0.4× 23 360
Andrea Renzullo Italy 8 153 0.7× 86 0.8× 77 0.9× 24 0.3× 43 0.7× 11 337
Svetlana Trofimov Israel 14 65 0.3× 156 1.5× 52 0.6× 50 0.6× 62 1.1× 28 427
G. Lamberigts Belgium 11 601 2.9× 104 1.0× 53 0.6× 14 0.2× 38 0.7× 16 726

Countries citing papers authored by Hal Landy

Since Specialization
Citations

This map shows the geographic impact of Hal Landy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hal Landy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hal Landy more than expected).

Fields of papers citing papers by Hal Landy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hal Landy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hal Landy. The network helps show where Hal Landy may publish in the future.

Co-authorship network of co-authors of Hal Landy

This figure shows the co-authorship network connecting the top 25 collaborators of Hal Landy. A scholar is included among the top collaborators of Hal Landy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hal Landy. Hal Landy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paller, Amy S., Elena Pope, Dan Rudin, et al.. (2022). A prospective short-term study to evaluate methodologies for the assessment of disease extent, impact, and wound evolution in patients with dystrophic epidermolysis bullosa. Orphanet Journal of Rare Diseases. 17(1). 314–314. 6 indexed citations
2.
Kishnani, Priya S., Robin Lachmann, Tahseen Mozaffar, et al.. (2019). Safety and efficacy of VAL-1221, a novel fusion protein targeting cytoplasmic glycogen, in patients with late-onset Pompe disease. Molecular Genetics and Metabolism. 126(2). S85–S86. 15 indexed citations
3.
Brewer, M. Kathryn, Tamar R. Grossman, Tracy R. McKnight, et al.. (2018). The 4th International Lafora Epilepsy Workshop: Shifting paradigms, paths to treatment, and hope for patients. Epilepsy & Behavior. 90. 284–286. 9 indexed citations
4.
Annoussamy, M., C. Lilien, G. Ollivier, et al.. (2015). Natural history and functional status of patients with myotubular myopathy enrolled in a prospective and longitudinal study. Neuromuscular Disorders. 25. S274–S274. 1 indexed citations
5.
Leung, Edward, Aizeddin A. Mhanni, Martin H. Reed, et al.. (2013). Outcome of Perinatal Hypophosphatasia in Manitoba Mennonites: A Retrospective Cohort Analysis. JIMD Reports. 11. 73–78. 55 indexed citations
6.
Whyte, Michael P., Priya S. Kishnani, C. R. Greenberg, et al.. (2012). Hypophosphatasia: Enzyme Replacement Therapy (Asfotase Alfa) Decreases TNSALP Substrate Accumulation And Improves Functional Outcomes In Affected Adolescents And Adults.. 51(1). 35. 6 indexed citations
7.
Whyte, Michael P., Cheryl R. Greenberg, Katherine L. Madson, et al.. (2012). Enzyme replacement therapy (ENB-0040) in hypophosphatasia improves functional outcome and decreases TNSALP substrates in adolescents and adults. Bone. 50. S39–S39.
8.
Bishop, Nick, Cheryl R. Greenberg, Mairead McGinn, et al.. (2011). Life-threatening hypophosphatasia (HPP): Results of up to two years bone-targeted Enzyme Replacement Therapy (ERT) in infants and young children. Bone. 48. S82–S82. 1 indexed citations
9.
Ezzat, Shereen, Simon Fear, Hal Landy, et al.. (2002). Gender-Specific Responses of Lean Body Composition and Non-Gender-Specific Cardiac Function Improvement after GH Replacement in GH-Deficient Adults. The Journal of Clinical Endocrinology & Metabolism. 87(6). 2725–2733. 70 indexed citations
10.
11.
Bercu, Barry B., et al.. (2001). Long-Term Therapy with Recombinant. Endocrine. 15(1). 43–50. 7 indexed citations
12.
Saenger, Paul, Ora Hirsch Pescovitz, Barry B. Bercu, et al.. (2001). Outcome of Growth Hormone Therapy in Children with Growth Hormone Deficiency Showing an Inadequate Response to Growth Hormone-Releasing Hormone. Endocrine. 15(1). 51–56. 2 indexed citations
13.
Savaraj, Niramol, Hal Landy, Shenghan Lai, et al.. (1997). Comparison of topoisomerase I and II expression in primary brain tumor and lung cancer. Oncology Reports. 4(4). 857–61. 3 indexed citations
14.
Thorner, Michael O., P Rochiccioli, M Colle, et al.. (1996). Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.. The Journal of Clinical Endocrinology & Metabolism. 81(3). 1189–1196. 37 indexed citations
15.
Mullenix, Phyllis J., et al.. (1994). Radiation Effects on Growth Are Altered in Rats by Prednisolone and Methotrexate. Pediatric Research. 35(4). 416–423. 21 indexed citations
16.
Appignani, B A, Hal Landy, & Patrick D. Barnes. (1994). MR in idiopathic central diabetes insipidus of childhood.. American Journal of Neuroradiology. 14(6). 1407–10. 16 indexed citations
17.
Landy, Hal, Paul A. Boepple, M. Joan Mansfield, et al.. (1991). Altered Patterns of Pituitary Secretion and Renal Excretion of Freeα-Subunit during Gonadotropin-Releasing Hormone Agonist-Induced Pituitary Desensitization*. The Journal of Clinical Endocrinology & Metabolism. 72(3). 711–717. 9 indexed citations
18.
Wolfsdorf, Joseph I., et al.. (1990). Glucose therapy for glycogenosis type 1 in infants: Comparison of intermittent uncooked cornstarch and continuous overnight glucose feedings. The Journal of Pediatrics. 117(3). 384–391. 22 indexed citations
19.
Landy, Hal, Paul A. Boepple, M. Joan Mansfield, et al.. (1990). Sleep Modulation of Neuroendocrine Function: Developmental Changes in Gonadotropin-Releasing Hormone Secretion during Sexual Maturation. Pediatric Research. 28(3). 213–217. 9 indexed citations
20.
Landy, Hal, Alan L. Schneyer, Randall W. Whitcomb, & W F Crowley. (1990). Validation of highly specific and sensitive radioimmunoassays for lutropin, follitropin, and free alpha subunit in unextracted urine. Clinical Chemistry. 36(2). 340–344. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pilar Andaluz Breakdown of academic impact, for papers by Nicola Improda Breakdown of academic impact, for papers by Hatae Maesaka Breakdown of academic impact, for papers by S. C. Cwyfan Hughes Breakdown of academic impact, for papers by J. Rodríguez‐Arnao Breakdown of academic impact, for papers by Sezer Acar Breakdown of academic impact, for papers by Dan Nabriski Breakdown of academic impact, for papers by Andrea Renzullo Breakdown of academic impact, for papers by Svetlana Trofimov Breakdown of academic impact, for papers by G. Lamberigts
Rankless by CCL
2026